statin therapy provides incremental clinical benefits in normocholesterolemic diabetic patients. 2010
Add to clipboard
2: Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. 2010
Add to clipboard
3: Clinical significance of mild lipid-lowering by statins for prevention of cardiovascular disease in Japanese high-risk patients. 2010
Add to clipboard
4: Modeling the 4D Study: statins and cardiovascular outcomes in long-term hemodialysis patients with diabetes. 2010
Add to clipboard
5: Efficacy and safety of statins in the treatment of diabetic dyslipidemia. 2010
Add to clipboard
6: Diabetes mellitus is a major negative determinant of coronary plaque regression during statin therapy in patients with acute coronary syndrome--serial intravascular ultrasound observations from the Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome Trial (the JAPAN-ACS Trial). 2010
Add to clipboard
7: Prevalence and overlap of different lipid abnormalities in statin-treated patients at high cardiovascular risk in clinical practice in Germany. 2010
Add to clipboard
8: Long-Term Statin Therapy is Associated with Better Episodic Memory in Aged Familial Hypercholesterolemia Patients in Comparison with Population Controls. 2010
Add to clipboard
9: HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trial. 2010
Add to clipboard
10: The effect of early and intensive statin therapy on ventricular premature beat or non-sustained ventricular tachycardia in patients with acute coronary syndrome. 2010
Add to clipboard
11: Statin Utilization in Nursing Home Patients after Cardiac Hospitalization. 2010
Add to clipboard
12: Statin use and decreased risk of benign prostatic enlargement and lower urinary tract symptoms. 2010
Add to clipboard
13: 3ST-POL trial: standards of statin use in Poland in the context of the European Society of Cardiology guidelines. 2010
Add to clipboard
14: Cost-Effectiveness of Using High-Sensitivity C-Reactive Protein to Identify Intermediate- and Low-Cardiovascular-Risk Individuals for Statin Therapy. 2010
Add to clipboard
15: Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170 255 patients from 76 randomized trials. 2010
Add to clipboard
16: Benefits of statin therapy and compliance in high risk cardiovascular patients. 2010
Add to clipboard
17: Effect of high dose statin therapy on platelet function; statins reduce aspirin-resistant platelet aggregation in patients with coronary heart disease. 2009
Add to clipboard
18: Apolipoproteins, cardiovascular risk and statin response in type 2 diabetes: the Collaborative Atorvastatin Diabetes Study (CARDS). 2009
Add to clipboard
19: Should we treat all patients with coronary heart disease or the equivalent with statins? 2009
Add to clipboard
20: Effect of previous treatment with statins on outcome of patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. 2009
Add to clipboard
21: [Are the guidelines correct? Should all patients with coronary heart disease or diabetes be treated with a statin?] 2009
Add to clipboard
22: N-3 polyunsaturated fatty acids and statins in heart failure. 2009
Add to clipboard
23: Effect of chronic statin pretreatment on hospital outcome in patients with acute non-ST-elevation myocardial infarction. 2009
Add to clipboard
24: Managing diabetic dyslipidemia: beyond statin therapy. 2009
Add to clipboard
25: Prevalence of cardiovascular comorbidities and utilization of evidence-based treatment strategies among statin users in a Medicare and commercial health plan. 2009
Add to clipboard
26: Cardiovascular disease in patients with renal disease: the role of statins. 2009
Add to clipboard
27: Managing statin myopathy. 2009
Add to clipboard
28: Preoperative statin use and infection after cardiac surgery: a cohort study. 2009
Add to clipboard
29: Factors influencing clopidogrel efficacy in patients with stable coronary artery disease undergoing elective percutaneous coronary intervention: statin's advantage and the smoking "paradox". 2009
Add to clipboard
30: The role of statins in the treatment of the metabolic syndrome. 2009
Add to clipboard
31: Prevalence of low low-density lipoprotein cholesterol with elevated high sensitivity C-reactive protein in the U.S.: implications of the JUPITER (Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin) study. 2009
Add to clipboard
32: The statins in prevention of coronary heart diseases in type 2 diabetics. 2009
Add to clipboard
33: Congestive heart failure is associated with lipoprotein components in statin-treated patients with coronary heart disease Insights from the Incremental Decrease in End points Through Aggressive Lipid Lowering Trial (IDEAL). 2009
Add to clipboard
34: Statins do not decrease the risk for wet age-related macular degeneration. 2009
Add to clipboard
35: Who does not need a statin: too late in end-stage renal disease or heart failure? 2009
Add to clipboard
36: Optimizing the start time of statin therapy for patients with diabetes. 2009
Add to clipboard
37: The Jupiter study, CRP screening, and aggressive statin therapy-implications for the primary prevention of cardiovascular disease. 2009
Add to clipboard
38: The gravity of JUPITER (Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin). 2009
Add to clipboard
39: Statins, ACE inhibitors and ARBs in cardiovascular disease. 2009
Add to clipboard
40: Impact of better adherence to statin agents in the primary prevention of coronary artery disease. 2009
Add to clipboard
41: Reducing morbidity and mortality in high risk patients with statins. 2009
Add to clipboard
42: Lipid lowering versus pleiotropic effects of statins on skin microvascular function in patients with dysglycaemia and coronary artery disease. 2009
Add to clipboard
43: The gender differences in baseline characteristics and statin intervention among outpatients with coronary heart disease in China: the China Cholesterol Education Program. 2009
Add to clipboard
44: Should clinicians deliver decision aids? Further exploration of the statin choice randomized trial results. 2009
Add to clipboard
45: Statins reduce appropriate cardioverter-defibrillator shocks and mortality in patients with heart failure and combined cardiac resynchronization and implantable cardioverter-defibrillator therapy. 2009
Add to clipboard
46: Statins for secondary cardiovascular disease prevention for older primary care patients. 2009
Add to clipboard
47: Plasma triglycerides and cardiovascular events in the Treating to New Targets and Incremental Decrease in End-Points through Aggressive Lipid Lowering trials of statins in patients with coronary artery disease. 2009
Add to clipboard
48: Role of statins in diabetes complications. 2009
Add to clipboard
49: Factors predicting cardiovascular events in statin-treated diabetic and non-diabetic patients with coronary atherosclerosis. 2009
Add to clipboard
50: [Effects of statins on coronary atherosclerotic plaque in patients with coronary heart disease and type 2 diabetes with mild elevated LDL-C] 2009
Add to clipboard
51: Are High-Risk Hypertensive Patients being Prescribed Concomitant Statin Therapy?: A Retrospective Cohort Study. 2009
Add to clipboard
52: Statin therapy and risk of developing type 2 diabetes: a meta-analysis. 2009
Add to clipboard
53: Long-term use of statins and risk of colorectal cancer: a population-based study. 2009
Add to clipboard
54: Incidence of perioperative myocardial infarction and of 2-year mortality in 577 elderly patients undergoing noncardiac vascular surgery treated with and without statins. 2009
Add to clipboard
55: An urgent matter-identifying your patients' cardiovascular risk and improving their outcomes. Low-density lipoprotein cholesterol and coronary heart disease: the importance of reaching target goals with statin therapy. 2009
Add to clipboard
56: Statin initiation by GPs in WA--a structured vignette study. 2009
Add to clipboard
57: The effect of statin therapy on the progression of carotid artery stenosis in relation to stenosis severity. 2009
Add to clipboard
58: Time for new indications for statins? 2009
Add to clipboard
59: [Effectiveness of ezetimibe in improving lipid goal attainment in patients with coronary heart diseases treated with statin] 2009
Add to clipboard
60: Impact of prior statin therapy on arrhythmic events in patients with acute coronary syndromes (from the Global Registry of Acute Coronary Events [GRACE]). 2009
Add to clipboard
61: Commentary to factors predicting cardiovascular events in statin-treated diabetic and non-diabetic patients with coronary atherosclerosis (1). 2009
Add to clipboard
62: Statin Therapy Decreases Myocardial Function as Evaluated Via Strain Imaging. 2009
Add to clipboard
63: [Gender difference in hipolipemic and anti-inflammatory effects of statins in diabetics with coronary artery disease] 2009
Add to clipboard
64: Questioning the"beatification"of statins. 2008
Add to clipboard
65: Effects of ezetimibe, simvastatin, atorvastatin, and ezetimibe-statin therapies on non-cholesterol sterols in patients with primary hypercholesterolemia. 2008
Add to clipboard
66: High-dose statin therapy for secondary prevention of stroke: stroke prevention by aggressive reduction in cholesterol levels study review. 2008
Add to clipboard
67: Effect of statins, angiotensin-converting enzyme inhibitors, and beta blockers on survival in patients >or=65 years of age with heart failure and preserved left ventricular systolic function. 2008
Add to clipboard
68: Preinjury statin use is associated with improved in-hospital survival in elderly trauma patients. 2008
Add to clipboard
69: The efficacy of statin monotherapy uptitration versus switching to ezetimibe/simvastatin: results of the EASEGO study. 2008
Add to clipboard
70: Should we prescribe statin and aspirin for every diabetic patient? Is it time for a polypill? 2008
Add to clipboard
71: Should we be more aggressive in the therapy against cardiovascular risk factors? Should we prescribe statin and aspirin for every diabetic patient, or is it time for a polypill? 2008
Add to clipboard
72: Optimal management of combined dyslipidemia: what have we behind statins monotherapy? 2008
Add to clipboard
73: Statin therapy for stroke prevention. 2008
Add to clipboard
74: [Clopidogrel and statins or once more on the danger of direct transfer of results of experimental studies in clinical practice] 2008
Add to clipboard
75: Effectiveness of ezetimibe alone or in combination with twice a week Atorvastatin (10 mg) for statin intolerant high-risk patients. 2008
Add to clipboard
76: Initiating statins in the elderly: the evolving challenge. 2008
Add to clipboard
77: Statins in the spectrum of neurologic disease. 2008
Add to clipboard
78: Clinical and public health assessment of benefits and risks of statins in primary prevention of coronary events: resolved and unresolved issues. 2008
Add to clipboard
79: Can cheap generic statins achieve national cholesterol lowering targets? 2008
Add to clipboard
80: Randomized clinical outcome trials of statins in heart failure. 2008
Add to clipboard
81: Cholesterol lowering is more important than pleiotropic effects of statins for endothelial function in patients with dysglycaemia and coronary artery disease. 2008
Add to clipboard
82: Statin therapy improves outcomes after valvular heart surgery. 2008
Add to clipboard
83: Erectile dysfunction as a predictor of cardiovascular events and death in diabetic patients with angiographically proven asymptomatic coronary artery disease: a potential protective role for statins and 5-phosphodiesterase inhibitors. 2008
Add to clipboard
84: Current status of cholesterol goal attainment after statin therapy among patients with hypercholesterolemia in Asian countries and region: the Return on Expenditure Achieved for Lipid Therapy in Asia (REALITY-Asia) study. 2008
Add to clipboard
85: Benefit of adding pioglitazone to successful statin therapy in nondiabetic patients with coronary artery disease. 2008
Add to clipboard
86: Equity in the use of antithrombotic drugs, beta-blockers and statins among Finnish coronary patients. 2008
Add to clipboard
87: Statins improve human coronary atherosclerotic plaque morphology. 2008
Add to clipboard
88: SLCO1B1 variants and statin-induced myopathy--a genomewide study. 2008
Add to clipboard
89: Do people with diabetes need statins? 2008
Add to clipboard
90: Effect of an intervention to increase statin use in medicare members who qualified for a medication therapy management program. 2008
Add to clipboard
91: Statin therapy alters the relationship between apolipoprotein B and low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol targets in high-risk patients: the MERCURY II (Measuring Effective Reductions in Cholesterol Using Rosuvastatin) trial. 2008
Add to clipboard
92: Who does not need a statin: too late in end-stage renal disease or heart failure? 2008
Add to clipboard
93: Ptosis, diplopia and statins: an association? 2008
Add to clipboard
94: Impact of adherence to statins on chronic heart failure in primary prevention. 2008
Add to clipboard
95: Statin therapy is associated with reduced total and cardiovascular mortality after coronary artery bypass grafting surgery. 2008
Add to clipboard
96: Effect of statins alone versus statins plus ezetimibe on carotid atherosclerosis in type 2 diabetes: the SANDS (Stop Atherosclerosis in Native Diabetics Study) trial. 2008
Add to clipboard
97: Statin therapy and mortality among patients hospitalized with heart failure and preserved left ventricular function--a preliminary report. 2008
Add to clipboard
98: Haplotypes in the lipoprotein lipase gene influence high-density lipoprotein cholesterol response to statin therapy and progression of atherosclerosis in coronary artery bypass grafts. 2007
Add to clipboard
99: Degeneration of native and tissue prosthetic valve in aortic position: do statins play an effective role in prevention? 2007
Add to clipboard
100: Statin use before by-pass surgery decreases the incidence and shortens the duration of postoperative atrial fibrillation. 2007
Add to clipboard
101: Social deprivation and statin prescribing: a cross-sectional analysis using data from the new UK general practitioner 'Quality and Outcomes Framework'. 2007
Add to clipboard
102: Case selection for statins was similar in two Canadian provinces: BC and Ontario. 2007
Add to clipboard
103: Ezetimibe added to statin therapy (EASY study) - an evaluation by Australian general practitioners. 2007
Add to clipboard
104: Statins prescribing for the secondary prevention of ischaemic heart disease in Torino, Italy. A case of ageism and social inequalities. 2007
Add to clipboard
105: Effect of statin therapy on survival in patients with nonischemic dilated cardiomyopathy (from the Beta-blocker Evaluation of Survival Trial [BEST]). 2007
Add to clipboard
106: Relationship between glycemic status and progression of carotid intima-media thickness during treatment with combined statin and extended-release niacin in ARBITER 2. 2007
Add to clipboard
107: Role of statins for the primary prevention of cardiovascular disease in patients with type 2 diabetes mellitus. 2007
Add to clipboard
108: Comparison of frequency of new-onset atrial fibrillation or flutter in patients on statins versus not on statins presenting with suspected acute coronary syndrome. 2007
Add to clipboard
109: Statin use in patients with extremely low low-density lipoprotein levels is associated with improved survival. 2007
Add to clipboard
110: Reduction in estimated risk for coronary artery disease after use of ezetimibe with a statin. 2007
Add to clipboard
111: Statin therapy for vascular failure. 2007
Add to clipboard
112: Lipoprotein lipase HindIII polymorphism influences HDL-cholesterol levels in statin-treated patients with coronary artery disease. 2007
Add to clipboard
113: Effect of pioglitazone and its combination with statins in coronary artery disease patients with hyperinsulinemia. 2007
Add to clipboard
114: Cost-effectiveness of raising HDL cholesterol by adding prolonged-release nicotinic acid to statin therapy in the secondary prevention setting: a French perspective. 2007
Add to clipboard
115: Patterns and predictors of statin use after coronary artery bypass graft surgery. 2007
Add to clipboard
116: Does statin therapy initiation increase the risk for myopathy? An observational study of 32,225 diabetic and nondiabetic patients. 2007
Add to clipboard
117: Statin use in Canadians: trends, determinants and persistence. 2007
Add to clipboard
118: Residual risk in statin-treated patients: future therapeutic options. 2007
Add to clipboard
119: A population-based analysis of statin utilization in British Columbia. 2007
Add to clipboard
120: Statins in hepatobiliary diseases: effects, indications and risks. 2007
Add to clipboard
121: Effects of statins beyond lipid lowering: potential for clinical benefits. 2006
Add to clipboard
122: Effect of statins on the mortality of patients with ischaemic heart disease: population based cohort study with nested case-control analysis. 2006
Add to clipboard
123: Statin/fibrate combination in patients with metabolic syndrome or diabetes: evaluating the risks of pharmacokinetic drug interactions. 2006
Add to clipboard
124: Statins for high-risk patients without heart disease or high cholesterol. 2006
Add to clipboard
125: Effect of statin treatment on coronary collateral development in patients with diabetes mellitus. 2006
Add to clipboard
126: Statins associated with reduced mortality in patients admitted for congestive heart failure. 2006
Add to clipboard
127: The broad-reaching power of statins. These"wonder"drugs offer an astounding range of benefits to treat--and prevent--heart disease. 2006
Add to clipboard
128: Statin safety: an assessment using an administrative claims database. 2006
Add to clipboard
129: Overcoming 'ageism' bias in the treatment of hypercholesterolaemia : a review of safety issues with statins in the elderly. 2006
Add to clipboard
130: Cholesterol, C-reactive protein, and cerebrovascular events following intensive and moderate statin therapy. 2006
Add to clipboard
131: Statin-associated pleiotropy: possible beneficial effects beyond cholesterol reduction. 2006
Add to clipboard
132: Are statins analogues of vitamin D? 2006
Add to clipboard
133: Statins: are any questions unanswered? 2006
Add to clipboard
134: Statins for diabetic cardiovascular complications. 2006
Add to clipboard
135: The reduction of inflammatory biomarkers by statin, fibrate, and combination therapy among diabetic patients with mixed dyslipidemia: the DIACOR (Diabetes and Combined Lipid Therapy Regimen) study. 2006
Add to clipboard
136: Niacin-ER/statin combination for the treatment of dyslipidemia: focus on low high-density lipoprotein cholesterol. 2006
Add to clipboard
137: Statins and the primary prevention of cardiovascular events. 2006
Add to clipboard
138: Association between the dosage and duration of statin treatment with coronary collateral development. 2006
Add to clipboard
139: High-dose statins for diabetes. 2006
Add to clipboard
140: [Statins and cardiovascular diseases] 2006
Add to clipboard
141: Who should receive a statin these days? Lessons from recent clinical trials. 2006
Add to clipboard
142: Does the metabolic syndrome help to select patients requiring high statin dose? 2006
Add to clipboard
143: Relation between soluble intercellular adhesion molecule-1, statin therapy, and long-term risk of clinical cardiovascular events in patients with previous acute coronary syndrome (from PROVE IT-TIMI 22). 2006
Add to clipboard
144: Atherogenic dyslipidemia in metabolic syndrome and type 2 diabetes: therapeutic options beyond statins. 2006
Add to clipboard
145: Incidence of new stroke or new myocardial infarction or death in patients with severe carotid arterial disease treated with and without statins. 2006
Add to clipboard
146: Factors associated with healthcare utilization costs for statin therapy--a pilot study in Hong Kong. 2006
Add to clipboard
147: Statin therapy and risks for death and hospitalization in chronic heart failure. 2006
Add to clipboard
148: [Statins (HMG-CoA reductase inhibitors)] 2006
Add to clipboard
149: Primary and secondary prevention of heart failure with statins. 2006
Add to clipboard
150: Comparison of the efficacy and safety of rosuvastatin 10 mg and atorvastatin 20 mg in high-risk patients with hypercholesterolemia--Prospective study to evaluate the Use of Low doses of the Statins Atorvastatin and Rosuvastatin (PULSAR). 2006
Add to clipboard
151: Management of dyslipidemia with statins in the patient with peripheral arterial disease. 2006
Add to clipboard
152: High cardiovascular risk in patients with diabetes and the cardiometabolic syndrome: mandate for statin therapy. 2006
Add to clipboard
153: Is atorvastatin superior to other statins? Analysis of the clinical trials with atorvastatin having cardiovascular endpoints. 2006
Add to clipboard
154: Statin use and the risk of Alzheimer's disease: the MIRAGE study. 2006
Add to clipboard
155: The influence of guidelines on the use of statins: analysis of prescribing trends 1998-2002. 2005
Add to clipboard
156: Statins decrease perioperative cardiac complications in patients undergoing noncardiac vascular surgery: the Statins for Risk Reduction in Surgery (StaRRS) study. 2005
Add to clipboard
157: Peripheral arterial disease: a missed opportunity to administer statins so as to reduce cardiac morbidity and mortality. 2005
Add to clipboard
158: Endothelium-ameliorating effects of statin therapy and coenzyme Q10 reductions in chronic heart failure. 2005
Add to clipboard
159: Do statins influence the prognostic impact of non-sustained ventricular tachycardia after ST-elevation myocardial infarction? 2005
Add to clipboard
160: Progression of aortic valve sclerosis and aortic valve stenosis: what is the role of statin treatment? 2005
Add to clipboard
161: Effects of switching statins on lipid and apolipoprotein ratios in the MERCURY I study. 2005
Add to clipboard
162: I've read that, because I have type 2 diabetes, I should take a statin even though my cholesterol levels are normal. Is this true? 2005
Add to clipboard
163: Persistence and determinants of statin therapy among middle-aged patients for primary and secondary prevention. 2005
Add to clipboard
164: Statins and CVD prevention in the diabetic population: implications of the CARDS trial. 2005
Add to clipboard
165: No effect of statin therapy on silent myocardial ischemia in patients with type 2 diabetes without manifest cardiovascular disease. 2005
Add to clipboard
166: Diabetes and progression of coronary calcium under the influence of statin therapy. 2005
Add to clipboard
167: The statin studies: from targeting hypercholesterolaemia to targeting the high-risk patient. 2005
Add to clipboard
168: Statin therapy may be associated with lower mortality in patients with diastolic heart failure: a preliminary report. 2005
Add to clipboard
169: Statin use after acute myocardial infarction: a nationwide study in Denmark. 2005
Add to clipboard
170: Does statin monotherapy address the multiple lipid abnormalities in type 2 diabetes? 2005
Add to clipboard
171: A case control study of age related macular degeneration and use of statins. 2005
Add to clipboard
172: Lipid management with statins in type 2 diabetes mellitus. 2005
Add to clipboard
173: Statins and LDL-cholesterol lowering: an overview. 2005
Add to clipboard
174: Relation of characteristics of metabolic syndrome to short-term prognosis and effects of intensive statin therapy after acute coronary syndrome: an analysis of the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) trial. 2005
Add to clipboard
175: The past, present, and future of statin therapy. 2005
Add to clipboard
176: A statin in the treatment of heart failure? Controlled rosuvastatin multinational study in heart failure (CORONA): study design and baseline characteristics. 2005
Add to clipboard
177: Stroke prevention, blood cholesterol and statins. 2005
Add to clipboard
178: Drug Insight: statins and stroke. 2005
Add to clipboard
179: Nonlipid-lowering effects of statins. 2005
Add to clipboard
180: Reducing residual risk for patients on statin therapy: the potential role of combination therapy. 2005
Add to clipboard
181: Statin therapy in Canadian patients with hypercholesterolemia: the Canadian Lipid Study -- Observational (CALIPSO). 2005
Add to clipboard
182: [Statins and stroke] 2005
Add to clipboard
183: The benefits of statin therapy--what questions remain? 2005
Add to clipboard
184: New and emerging data from clinical trials of statins. 2004
Add to clipboard
185: Association between long-term statin use and mortality after successful abdominal aortic aneurysm surgery. 2004
Add to clipboard
186: Statin treatment and the natural history of atherosclerotic-related diseases: pathogenic mechanisms and the risk-benefit profile. 2004
Add to clipboard
187: Statin therapy is associated with improved survival in ischemic and non-ischemic heart failure. 2004
Add to clipboard
188: Undertreatment and overtreatment with statins: the Oslo Health Study 2000-2001. 2004
Add to clipboard
189: Effects of switching statins on achievement of lipid goals: Measuring Effective Reductions in Cholesterol Using Rosuvastatin Therapy (MERCURY I) study. 2004
Add to clipboard
190: Meta-analysis of large randomized controlled trials to evaluate the impact of statins on cardiovascular outcomes. 2004
Add to clipboard
191: Lipid-lowering therapy with statins in high-risk elderly patients: the treatment-risk paradox. 2004
Add to clipboard
192: Association of dyslipidemia and effects of statins on nonmacrovascular diseases. 2004
Add to clipboard
193: Statin therapy is associated with lower mortality among patients with severe heart failure. 2004
Add to clipboard
194: Statins in atherosclerosis: lipid-lowering agents with antioxidant capabilities. 2004
Add to clipboard
195: Quantifying the effect of applying the NCEP ATP III criteria in a managed care population treated with statin therapy. 2004
Add to clipboard
196: The cardioprotective effects of statins. 2004
Add to clipboard
197: Cardiovascular outcomes among participants with diabetes in the recent large statin trials. 2004
Add to clipboard
198: Impact of angiotensin-converting enzyme inhibitors and statins on survival in idiopathic pulmonary fibrosis. 2004
Add to clipboard
199: Statins for all patients with type 2 diabetes: not so soon. 2004
Add to clipboard
200: Should angiotensin II receptor blockers and statins be combined? 2004
Add to clipboard
201: A combination of statins and beta-blockers is independently associated with a reduction in the incidence of perioperative mortality and nonfatal myocardial infarction in patients undergoing abdominal aortic aneurysm surgery. 2004
Add to clipboard
202: Statin-induced cholesterol lowering and plaque regression after 6 months of magnetic resonance imaging-monitored therapy. 2004
Add to clipboard
203: [Statins: therapeutic cascade of their effects] 2004
Add to clipboard
204: The potential role of statins in contrast nephropathy. 2004
Add to clipboard
205: Statins: can the new generation make an impression? 2004
Add to clipboard
206: Statin therapy in the primary and secondary prevention of coronary artery disease in patients with type 2 diabetes. A scientific review. 2004
Add to clipboard
207: Level of awareness of on-treatment patients about prescribed statins. 2004
Add to clipboard
208: Frequency of statin use in type 2 diabetics having macrovascular disease- at a Tertiary Care Hospital of Karachi. 2004
Add to clipboard
209: Statins and diabetes. 2004
Add to clipboard
210: Expanding indications of statins; implications of the Heart Protection Study. 2003
Add to clipboard
211: Efficacy of rosuvastatin compared with other statins at selected starting doses in hypercholesterolemic patients and in special population groups. 2003
Add to clipboard
212: [Statin treatment in type 2 diabetes. Is it a must today?] 2003
Add to clipboard
213: Effect of statins on mortality and cardiovascular events in elderly high-risk persons. 2003
Add to clipboard
214: Statins. Evidence of effectiveness in older patients. 2003
Add to clipboard
215: Cost effectiveness of statin therapy for the primary prevention of major coronary events in individuals with type 2 diabetes. 2003
Add to clipboard
216: Statins, super-statins and cholesterol absorption inhibitors. 2003
Add to clipboard
217: Elderly diabetics with peripheral arterial disease and no coronary artery disease have a higher incidence of new coronary events than elderly nondiabetics with peripheral arterial disease and prior myocardial infarction treated with statins and with no lipid-lowering drug. 2003
Add to clipboard
218: The impact of statin treatment on diabetic patients. 2003
Add to clipboard
219: Potential nontraditional applications of statins. 2003
Add to clipboard
220: Lipid and nonlipid benefits of statins. 2003
Add to clipboard
221: Effects of statins on C-reactive protein and interleukin-6 (the Ludwigshafen Risk and Cardiovascular Health study). 2003
Add to clipboard
222: Statins: new data in secondary prevention and diabetes. Pravastatin and simvastatin are the best-assessed statins. 2003
Add to clipboard
223: Hypercholesterolemia. The evidence supports use of statins. 2003
Add to clipboard
224: Statins indispensable for people with diabetes. 2003
Add to clipboard
225: Anti-inflammatory effects of statins in patients with aortic stenosis. 2003
Add to clipboard
226: Statins and renal function in patients with diabetes mellitus. 2003
Add to clipboard
227: Benefits of statin treatment in cardiac syndrome-X1. 2003
Add to clipboard
228: Cardiovascular disease with diabetes or the metabolic syndrome: should statins or fibrates be first line lipid therapy? 2003
Add to clipboard
229: Statins for everybody? New evidence on the efficacy and safety of the inhibitors of HMG Co-A reductase. 2003
Add to clipboard
230: The impact of reimbursement criteria on the appropriateness of 'statin' prescribing. 2003
Add to clipboard
231: Do Singapore patients require lower doses of statins? The SGH Lipid Clinic experience. 2003
Add to clipboard
232: [Even at LDL cholesterol 100mg/dl."Every coronary disease patient has to receive a statin"] 2003
Add to clipboard
233: Long-term statin safety and efficacy in secondary prevention: can combination therapy improve outcomes? 2003
Add to clipboard
234: Management of dyslipidemias in the age of statins. 2003
Add to clipboard
235: Patients with acute coronary syndromes should received statins. 2002
Add to clipboard
236: Effect of very-low-dose niacin on high-density lipoprotein in patients undergoing long-term statin therapy. 2002
Add to clipboard
237: Statin-induced fibrotic nonspecific interstitial pneumonia. 2002
Add to clipboard
238: High persistence of statin use in a Danish population: compliance study 1993-1998. 2002
Add to clipboard
239: Incidence of new atherothrombotic brain infarction in older persons with prior myocardial infarction and serum low-density lipoprotein cholesterol >or=125 mg/dl treated with statins versus no lipid-lowering drug. 2002
Add to clipboard
240: [Taking statins immediately after heart catheterization. Rate of complications is cut in half in diabetic patients] 2002
Add to clipboard
241: Reduction of coronary events with aspirin in older patients with prior myocardial infarction treated with and without statins. 2002
Add to clipboard
242: The choice of hormone replacement therapy or statin therapy in the treatment of hyperlipidemic postmenopausal women. 2002
Add to clipboard
243: Adherence to statin treatment and readmission of patients after myocardial infarction: a six year follow up study. 2002
Add to clipboard
244: Comparing the effects of five different statins on the HDL subpopulation profiles of coronary heart disease patients. 2002
Add to clipboard
245: Answering the unanswered questions: ongoing trials of statins and antihypertensives in type 2 diabetes. 2002
Add to clipboard
246: Getting more people on statins. 2002
Add to clipboard
247: Clinical significance of pleiotropic effects of statins: lipid reduction and beyond. 2002
Add to clipboard
248: Reduction of new coronary events and new atherothrombotic brain infarction in older persons with diabetes mellitus, prior myocardial infarction, and serum low-density lipoprotein cholesterol >/=125 mg/dl treated with statins. 2002
Add to clipboard
249: [Broader indication for treatment with statins; the 'heart protection study'] 2002
Add to clipboard
250: [Treatment with statins: further data from the Heart Protection Study] 2002
Add to clipboard
251: Wider role seen for"remarkable";statins. Study suggests that benefits extend even to those with"normal"cholesterol levels. 2002
Add to clipboard
252: Does pretreatment with statins improve clinical outcome after stroke? A pilot case-referent study. 2001
Add to clipboard
253: [Ongoing clinical trials by vascular statin, cerivastatin] 2001
Add to clipboard
254: What do the statin trials tell us? 2001
Add to clipboard
255: Treating dyslipidaemia in non-insulin-dependent diabetes mellitus -- a special reference to statins. 2001
Add to clipboard
256: What do the statin trials tell us? 2001
Add to clipboard
257: Ongoing clinical trials of statins. 2001
Add to clipboard
258: Association of coronary risk factors and use of statins with progression of mild valvular aortic stenosis in older persons. 2001
Add to clipboard
259: Cost-effectiveness of prescribing statins according to pharmaceutical benefits scheme criteria. 2001
Add to clipboard
260: [Can we afford good cholesterol lowering therapy? Budgeting of statin costs versus medical needs in the county of Stockholm] 2001
Add to clipboard
261: Cost-effectiveness of statins. 2000
Add to clipboard
262: [Weight reduction, statins or fibrates? How to reach lipid goal values in diabetic patients] 2000
Add to clipboard
263: Statin therapy, lipid levels, C-reactive protein and the survival of patients with angiographically severe coronary artery disease. 2000
Add to clipboard
264: Statins: where are we now? 2000
Add to clipboard
265: [Statins--new mechanisms of action and new indications] 2000
Add to clipboard
266: [Statins in secondary prevention of coronary heart disease] 1999
Add to clipboard
267: [Statins in diabetic hyperlipidemia] 1999
Add to clipboard
268: [Statins--attaining goal values--with reference to recent studies] 1999
Add to clipboard
